Table 3 Use of antihypertensive medicines by dose product: use in defined daily dose [DDD] and proportion within all single-medicine dose products [%] in Ghana and Nigeria

1

Candesartan

16

153,812

16

Furosemide

40

397,284

12.2

2

Nifedipine

30

119,532

12.4

Amlodipine

5

394,230

12.1

3

Amlodipine

5

101,778

10.6

Losartan

50

271,533

8.3

4

Candesartan

8

83,653

8.7

Nifedipine

30

265,585

8.2

5

Losartan

50

75,340

7.8

Lisinopril

10

234,870

7.2

6

Lisinopril

10

72,950

7.6

Losartan

100

194,982

6

7

Indapamide

1.5

65,332

6.8

Lisinopril

20

149,234

4.6

8

Nifedipine

20

38,309

4

HCT

50

148,244

4.6

9

Lisinopril

20

37,944

3.9

Nifedipine

20

142,915

4.4

10

Atenolol

50

26,014

2.7

Valsartan

160

128,352

3.9

11

Candesartan

32

23,096

2.4

Valsartan

80

111,478

3.4

12

Lisinopril

5

18,110

1.9

Methyldopa

250

107,321

3.3

13

Valsartan

160

17,784

1.8

Telmisartan

80

92,180

2.8

14

Losartan

100

17,044

1.8

Indapamide

1.5

74,382

2.3

15

Valsartan

80

7720

0.8

Atenolol

50

73,747

2.3

16

Nifedipine

10

2648

0.3

Telmisartan

40

55,627

1.7

17

Methyldopa

500

2345

0.2

Losartan

25

51,395

1.6

18

Methyldopa

250

2184

0.2

Lisinopril

5

33,969

1

19

Furosemide

40

1951

0.2

Atenolol

100

31,380

1

20

Valsartan

320

1580

0.2

Candesartan

16

21,002

0.6

21

Atenolol

100

795

0.1

Atenolol

25

16,429

0.5

22

Furosemide

20

17

0

Candesartan

8

12,201

0.4

23

Atenolol

25

1

0

Furosemide

20

1648

0.1

24

Losartan

25

–

0

Amlodipine

2.5

501

0

25

Amlodipine

2.5

–

0

Valsartan

320

–

0

26

HCT

50

–

0

Nifedipine

10

–

0

27

Telmisartan

80

–

0

Methyldopa

500

–

0

28

Telmisartan

40

–

0

Candesartan

32

–

0

Total

962,650

3,252,329

Top 10 (% all use)

80.5

71.6